WELCOME

The UCLA SARx is dedicated to the discovery, development, and dissemination of effective medications for the treatment of addiction. We are part of the Center for Behavioral and Addiction Medicine within the Department of Family Medicine at the UCLA David Geffen School of Medicine.

Tuesday, March 08, 2011

Research Papers

2010
  • Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence (link)
2009
  • Treatment for amphetamine withdrawal (link)
  • Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables (link)
  • The cardiovascular and subjective effects of methamphetamine combined with γ-vinyl-γ-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers (link)
2008
  • Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence (link)
  • Bupropion Hydrochloride versus Placebo, in Combination with Cognitive Behavioral Therapy, for the Treatment of Cocaine Abuse/Dependence (link)
2006
  • Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence (link)